PNOC
Prepronociceptin
Also known as: N/OFQ, NOP, PNOC_HUMAN, PPNOC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13519
- Gene
- PNOC
- Ensembl
- ENSG00000168081
- Chromosome
- 8
- Canonical length
- 176 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins, Transporters
- Subcellular location
- Vesicles
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a preproprotein that is proteolytically processed to generate multiple protein products. These products include nociceptin, nocistatin, and orphanin FQ2 (OFQ2). Nociceptin, also known as orphanin FQ, is a 17-amino acid neuropeptide that binds to the nociceptin receptor to induce increased pain sensitivity, and may additionally regulate body temperature, learning and memory, and hunger. Another product of the encoded preproprotein, nocistatin, may inhibit the effects of nociceptin. [provided by RefSeq, Jul 2015]
Canonical amino-acid sequenceUniProt
176 residues, UniProt reviewed canonical sequence.
>Q13519|PNOC
1 MKVLLCDLLL LSLFSSVFSS CQRDCLTCQE KLHPALDSFD LEVCILECEE KVFPSPLWTP
61 CTKVMARSSW QLSPAAPEHV AAALYQPRAS EMQHLRRMPR VRSLFQEQEE PEPGMEEAGE
121 MEQKQLQKRF GGFTGARKSA RKLANQKRFS EFMRQYLVLS MQSSQRRRTL HQNGNVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PNOC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 28 nTPM
- lymph node: 23 nTPM
- tonsil: 22 nTPM
- fallopian tube: 17 nTPM
- spleen: 14 nTPM
- appendix: 9.3 nTPM
Single-cell type
- plasma cells: 100 nCPM
- b-cells: 43 nCPM
- fallopian secretory cells: 43 nCPM
- pdcs: 35 nCPM
- brain inhibitory neurons: 20 nCPM
- other brain neurons: 16 nCPM
Immune cell
- naive B-cell: 262 nTPM
- memory B-cell: 232 nTPM
- plasmacytoid DC: 195 nTPM
- classical monocyte: 12 nTPM
- total PBMC: 11 nTPM
- intermediate monocyte: 7.7 nTPM
Brain region
- spinal cord: 30 nTPM
- medulla oblongata: 21 nTPM
- cerebral cortex: 20 nTPM
- pons: 19 nTPM
- hypothalamus: 19 nTPM
- midbrain: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.64
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chemical synaptic transmission
- female pregnancy
- neuron-neuron synaptic transmission
- neuropeptide signaling pathway
- sensory perception
- sensory perception of pain
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PNOC as an antibody target. Whether an autoantibody or antibody against PNOC could matter depends on whether native PNOC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PNOC is annotated as secreted, so native PNOC circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PNOC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...